SCI Stock Recent News

Service Corporation International is well-positioned post-pandemic, benefiting from an aging population and potential corporate tax cuts, with a 'Strong Buy' rating and a fair value of $98 per share. The company experienced significant growth during the pandemic, and despite a recent decline, funeral volumes are expected to normalize, with cemetery revenue showing robust growth. Service Corporation's extensive US network enhances sales productivity and cost optimization, while potential tax cuts could significantly boost net income.

VIENNA, Va.--(BUSINESS WIRE)---- $CVM #Multikine--CEL-SCI reports new data. Treatment with Multikine resulted in up to 95% improvement in Quality of Life for Head and Neck Cancer Patients.

VIENNA, Va.--(BUSINESS WIRE)---- $CVM--CEL-SCI announces closing of $2.5 million offering .

VIENNA, Va.--(BUSINESS WIRE)---- $CVM--CEL-SCI announces pricing of $2.5 million offering.

VIENNA, Va.--(BUSINESS WIRE)---- $CVM #Multikine--Journal of the American Medical Association study provides further evidence that Multikine can treat unmet need in ~70% of Head and Neck Patients.

NASHVILLE, Tenn., March 04, 2025 (GLOBE NEWSWIRE) -- UPAY Inc. ("UPAY" or the "Company") (OTCQB: UPYY) is pleased to announce the successful participation of its subsidiary, HUNTPAL, at the 2024 Safari Club International (SCI) Annual Convention and the Ultimate Sportsmen's Market. This prestigious event, held at the Music City Center in Nashville, Tennessee, brought together thousands of passionate hunters, outfitters, and industry leaders from around the world, celebrating SCI's ongoing commitment to hunting advocacy and wildlife conservation.

SCI announces a 6.7% dividend increase, reinforcing its commitment to shareholder value and financial strength.

HOUSTON , Feb. 20, 2025 /PRNewswire/ -- Service Corporation International (NYSE: SCI), the largest provider of deathcare products and services in North America, today announced that its Board of Directors has approved an increase in its quarterly cash dividend to thirty two cents per share of common stock. This quarterly cash dividend declared today represents a 6.7% increase from the previously declared quarterly dividend of thirty cents per share of common stock per quarter.

VIENNA, Va.--(BUSINESS WIRE)---- $CVM #Multikine--CEL-SCI to initiate Multikine Confirmatory Phase 3 Cancer Trial.

VIENNA, Va.--(BUSINESS WIRE)---- $CVM #Multikine--CEL-SCI reports fiscal Q1 2025 financial results: Multikine shows pre-surgical tumor elimination and regression in just 3 weeks.